IDERA
Idera Pharmaceuticals, Inc.
Application Filed: 2005-06-28
Trademark Application Details
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78660224 |
| Registration Number | 3684484 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Rebecca E. McDougall |
| Attorney Docket Number | 105968.0012 |
| Law Office Assigned | M70 |
| Employee Name | GAAFAR, SAMIR MICHAEL |
Timeline
| 2005-06-28 | Application Filed |
| 2006-10-31 | Published for Opposition |
| 2008-06-02 | Date of First Use |
| 2009-09-15 | Trademark Registered |
| 2015-10-27 | Status: Live/Registered |
| 2019-09-25 | Location: TMO LAW OFFICE 116 |
| 2019-09-26 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  IDERA PHARMACEUTICALS, INC. |
| Address | 167 Sidney Street CAMBRIDGE DE 02139 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-07-05 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2006-01-19 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2006-01-30 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2006-01-30 | 4 GNRT F:First Action |
| PAPER RECEIVED | 2006-07-28 | 5 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2006-07-28 | 6 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2006-08-15 | 7 ACEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2006-09-05 | 8 CNSA P: |
| ASSIGNED TO LIE | 2006-09-08 | 9 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2006-09-15 | 10 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2006-10-11 | 11 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-10-31 | 12 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2007-01-23 | 13 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2007-07-03 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2007-07-03 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2007-07-03 | 16 EX1G S: |
| TEAS EXTENSION RECEIVED | 2008-01-23 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2008-01-23 | 18 EXT2 S: |
| EXTENSION 2 GRANTED | 2008-02-08 | 19 EX2G S: |
| TEAS EXTENSION RECEIVED | 2008-07-23 | 20 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2008-07-23 | 21 EXT3 S: |
| EXTENSION 3 GRANTED | 2008-07-23 | 22 EX3G S: |
| TEAS EXTENSION RECEIVED | 2009-01-15 | 23 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2009-01-15 | 24 EXT4 S: |
| EXTENSION 4 GRANTED | 2009-01-15 | 25 EX4G S: |
| TEAS STATEMENT OF USE RECEIVED | 2009-07-06 | 26 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2009-07-06 | 27 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2009-07-28 | 28 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2009-07-06 | 29 EXT5 S: |
| EXTENSION 5 GRANTED | 2009-07-28 | 30 EX5G S: |
| USE AMENDMENT FILED | 2009-07-06 | 31 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2009-07-28 | 32 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2009-07-31 | 33 CNPR P: |
| ASSIGNED TO LIE | 2009-08-10 | 34 ALIE A:Allowance for Publication |
| LAW OFFICE REGISTRATION REVIEW COMPLETED | 2009-08-11 | 35 REGV O:Outgoing Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2009-09-15 | 36 R.PR A:Allowance for Publication |
| TEAS SECTION 8 & 15 RECEIVED | 2015-09-10 | 37 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2015-10-27 | 38 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2015-10-27 | 39 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2015-10-27 | 40 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2018-09-15 | 41 REM2 E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-04-23 | 42 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-04-23 | 43 ARAA I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2019-09-16 | 44 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2019-09-24 | 45 APRE A:Allowance for Publication |
| POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | 2019-09-25 | 46 PR89 O:Outgoing Correspondence |
| CANCELLED SEC. 8 (10-YR) | 2020-03-26 | 47 C8.T O:Outgoing Correspondence |
| NOTICE OF CANCELLATION SEC. 8 EMAILED | 2020-03-27 | 48 NCS8 E:E-Mail |
| TEAS PETITION TO DIRECTOR RECEIVED | 2020-04-06 | 49 TPDR I:Incoming Correspondence |
| ASSIGNED TO PETITION STAFF | 2020-07-28 | 50 APET A:Allowance for Publication |
| PETITION INQUIRY LETTER ISSUED | 2020-07-29 | 51 PILM I:Incoming Correspondence |
| TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY | 2020-08-17 | 52 ERTI I:Incoming Correspondence |
| PETITION TO DIRECTOR - GRANTED | 2020-08-21 | 53 PCGR O:Outgoing Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2020-08-21 | 54 APRE A:Allowance for Publication |
| REINSTATED | 2020-08-21 | 55 REIN I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2020-08-21 | 56 APRE A:Allowance for Publication |
| POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | 2020-08-24 | 57 PR89 O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | 2021-02-22 | 58 EROP I:Incoming Correspondence |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2021-02-24 | 59 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2021-02-24 | 60 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2021-02-24 | 61 NA89 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 